Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/04/2012US8324178 Method of treatment using alpha-1-adrenergic agonist compounds
12/04/2012US8324177 Triterpene compositions and methods for use thereof
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8324175 Compositions and methods for the treatment of cancer
12/04/2012US8324171 Ophthalmic compositions containing diglycine
12/04/2012US8324167 Treatment of T-cell mediated diseases
12/04/2012US8324155 Quinoxaline-containing compounds as hepatitis C virus inhibitors
12/04/2012US8324148 Delivering to the subject a compound comprising a nuclear localization sequence of NF-kB such that nuclear importation of NF-kB is inhibited
12/04/2012US8324130 Synergistic active ingredient combinations
12/04/2012US8323706 Administering extract from soy plants grown under stressed conditions; inhibiting selective estrogen receptor modulator induced uterotrophic effects
12/04/2012US8323705 Foods, drug containing cocoa and proanthocyanidin; adjust concentration of nitrogen oxide; hypotensive agents; cardiovascular disorders
12/04/2012US8323680 Nutritional composition
12/04/2012US8323674 Synergistic biocide composition comprising 2-methylisothiazoline-3-one
12/04/2012US8323673 Concentrated, non-foaming solution of quaternary ammonium compounds and methods of use
12/04/2012US8323671 Prolyl hydroxylase inhibitors and methods of use
12/04/2012US8323670 Topical compositions of opioid antagonists and methods for treating skin conditions therewith
12/04/2012US8323669 Polymer conjugate of taxane
12/04/2012US8323654 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
12/04/2012US8323644 Therapy-enhancing glucan
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323633 Antiviral method
12/04/2012US8323632 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
12/04/2012US8323631 UV-absorbers for ophthalmic lens materials
12/04/2012US8323630 Self-preserved aqueous pharmaceutical compositions
12/04/2012US8323629 External preparation for the skin
12/04/2012US8323621 site-directed delivery of contrast agent; brain or breast cancer; 1,4,7,10 tetraazacyclododecane having variable chelating ions, phosphoester chains, and light harvesting moieties for changing imaging methods; conjugated to high affinity PBR ligand PK11195; bound to a PVA or a PEG delivery vehicle
12/04/2012US8323617 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
12/04/2012US8323615 Methods of processing multi-phasic dispersions
12/04/2012US8323513 Dewatering biomass material comprising polysaccharide, method for extracting polysaccharide from biomass material, and dewatered biomass material
12/04/2012US8323266 Fluid medication delivery device
12/04/2012US8323263 System with a reservoir for perfusion management
12/04/2012CA2716874C A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
12/04/2012CA2713025C Kappa selective opioid receptor antagonist
12/04/2012CA2708703C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
12/04/2012CA2696977C Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof
12/04/2012CA2695973C Novel salt of isoquinoline compound and crystal thereof
12/04/2012CA2694401C Polycyclic compound
12/04/2012CA2687265C P70 s6 kinase inhibitors
12/04/2012CA2684149C Metabolites of (thio)carbamoyl-cyclohexane derivatives
12/04/2012CA2678135C Method for increasing hair growth using a creatine compound
12/04/2012CA2675724C Oral extended-release composition
12/04/2012CA2674543C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/04/2012CA2672019C Thiol-modified macromolecule derivatives and cross-linked materials thereof
12/04/2012CA2665049C Hcv nucleoside inhibitor
12/04/2012CA2663511C Thiazole pyrazolopyrimidines as crf1 receptor antagonists
12/04/2012CA2645205C Stable aqueous suspension having palatable taste
12/04/2012CA2640396C New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
12/04/2012CA2622760C Cyclopropyl amines as modulators of the histamine h3 receptor
12/04/2012CA2618362C Hindered cyclic polyamines and their salts for acid gas scrubbing process
12/04/2012CA2617363C Use of ivabradine for the manufacture of medications for the treatment of endothelial dysfunction
12/04/2012CA2600203C New salt and polymorphs of a dpp-iv inhibitor
12/04/2012CA2591307C Injectable veterinary composition
12/04/2012CA2590204C Amide compounds and thrombopoietin receptor activators
12/04/2012CA2589252C Ameliorant for renal insufficiency
12/04/2012CA2582934C Composition containing omega-3 fatty acids and omega-6 fatty acids
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2572743C Methods for improving bioavailability of a renin inhibitor
12/04/2012CA2568997C Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
12/04/2012CA2567003C Pyrimidine derivatives which are antagonists of the vitronectin receptor
12/04/2012CA2562189C Azacyclosteroid histamine-3 receptor ligands
12/04/2012CA2561313C Methods for minimizing thioamide impurities
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2551751C Osmotic device containing a venlafaxine salt and a salt having an ion in common
12/04/2012CA2551493C Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
12/04/2012CA2548323C Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
12/04/2012CA2547586C Controlled-release pharmaceutical formulation
12/04/2012CA2538078C Rifalazil formulations
12/04/2012CA2537748C Use of telmisartan for the prevention of vascular headache
12/04/2012CA2534338C Transdermal formulation comprising an opioid analgesic and an aloe composition
12/04/2012CA2529441C Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
12/04/2012CA2526989C Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
12/04/2012CA2520732C Migrastatin analogs and uses thereof
12/04/2012CA2520613C Implantable polymeric device for sustained release of dopamine agonist
12/04/2012CA2518932C 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/04/2012CA2515745C Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
12/04/2012CA2501282C Vasoregulating compounds and methods of their use
12/04/2012CA2485491C Injectable compositions comprising flunixin and florfenicol for treating infection in cattle and swine
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2427043C Novel intermediates for use in retinoid synthesis
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2261630C Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
12/04/2012CA2222509C Connective tissue growth factor
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
11/2012
11/29/2012WO2012162698A1 Methods and compositions for the treatment of immune disorders
11/29/2012WO2012162697A1 Compounds that modulate autoimmunity and methods of using the same
11/29/2012WO2012162669A1 Methods of treating multiple sclerosis and preserving and/or increasing myelin content
11/29/2012WO2012162635A1 Metabotropic glutamate receptors 5 modulators and methods of use thereof
11/29/2012WO2012162629A2 Popcorn shape gold nanoparticle for targeted diagnosis, photothermal treatment and in-situ monitoring therapy response for cancer and multiple drug resistance bacteria
11/29/2012WO2012162627A1 Treatment of angiogenic- or vascular-associated diseases
11/29/2012WO2012162584A1 Combination therapy of hsp90 inhibitory compounds with chk inhibitors
11/29/2012WO2012162580A2 Anti-viral compounds
11/29/2012WO2012162578A2 Anti-viral compounds
11/29/2012WO2012162555A2 Heparin nanoclusters
11/29/2012WO2012162531A1 Inhibitors of galectin-3 and methods of use thereof
11/29/2012WO2012162513A2 Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors
11/29/2012WO2012162507A1 Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereof
11/29/2012WO2012162468A1 Thiazol derivatives as pro -matrix metalloproteinase inhibitors
11/29/2012WO2012162463A1 Benzothiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012WO2012162461A1 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012WO2012162439A2 Compositions comprising fusidic acid and packages therefor
1 ... 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 ... 7860